Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Try Restylane® Eyelight™ for Tired-looking Eyes at Laser & Cosmetic Surgery Specialists
  • USA - English


News provided by

Laser & Cosmetic Surgery Specialists

Jun 22, 2023, 00:00 ET

Share this article

Share toX

Share this article

Share toX

A female patient at Laser & Cosmetic Surgery and Specialists after receiving Restylane Eyelight treatment.
A female patient at Laser & Cosmetic Surgery and Specialists after receiving Restylane Eyelight treatment.

Dr. Ran Rubinstein, a certified trainer selected by Galderma, now offers the innovative, FDA-approved Restylane® Eyelight™ treatment for under-eye shadow correction at Laser & Cosmetic Surgery Specialists in Newburgh, NY.

NEWBURGH, N.Y., June 22, 2023 /PRNewswire-PRWeb/ -- The battle against aging and tired-looking eyes has a new ally with Laser & Cosmetic Surgery Specialists introducing the latest addition to their range of top-tier aesthetic services: Restylane® Eyelight™. This groundbreaking treatment targets under-eye shadows, a common concern for many, with an innovative hyaluronic acid-based filler designed to refresh and rejuvenate the eye area.

Steering the helm of this advanced offering is the highly respected facial plastic surgeon Dr. Ran Rubinstein. With over 20 years of experience and a commitment to staying at the forefront of industry advancements, Dr. Rubinstein is now bringing the benefits of Restylane® Eyelight™ to his valued patients.

In an industry where staying current is crucial, Dr. Rubinstein not only offers the most innovative treatments but is also an active contributor to the advancement of aesthetic medicine. He has been selected as a certified national trainer for Restylane® Eyelight™ by Galderma, the global dermatology company behind the product. This significant recognition endorses his vast experience and expertise, and it's with great honor that he will be teaching other professionals to perform this transformative procedure.

With the introduction of Restylane® Eyelight™, Laser & Cosmetic Surgery Specialists continue their commitment to provide their patients with the highest standards of care. This innovative treatment signifies a remarkable leap forward in the fight against tired-looking eyes, and the practice is thrilled to guide its patients through their aesthetic journey, helping them achieve their desired outcomes.

What is Restylane® Eyelight™?
Restylane® Eyelight™ is a breakthrough in aesthetic medicine, providing a non-surgical, FDA-approved solution for individuals troubled by the appearance of under-eye shadows. This condition, often associated with fatigue and aging, is now effectively treatable with an innovative approach courtesy of Galderma, a leading global dermatology company.

Restylane® Eyelight™ utilizes a hyaluronic acid-based filler, a substance naturally found in the human body and known for its hydration and volume-enhancing properties. The treatment targets the under-eye area, diminishing the appearance of shadows and bringing patients a fresh, revitalized look.

The science behind Restylane® Eyelight™ is based on Galderma's patented Non-Animal Stabilized Hyaluronic Acid (NASHA) technology. This cross-linking technology creates a firmer gel-like substance that is ideal for filling under-eye hollows and softening the appearance of shadows. The safety and efficacy of NASHA gel technology have been extensively evaluated, earning the trust of healthcare practitioners worldwide for over 25 years.

The FDA approval of Restylane® Eyelight™ signifies a significant step forward in aesthetic medicine, emphasizing its safety and efficacy for patient use. The procedure promises to usher in a new era in under-eye treatment options, providing a compelling solution for those desiring a more youthful and alert appearance without undergoing invasive surgery.

The application of Restylane® Eyelight™ is a meticulous process, requiring a provider with thorough knowledge of anatomy and experience. That's why choosing a board-certified facial plastic surgeon like Dr. Ran Rubinstein ensures the best possible results.

Dr. Rubinstein Selected as a Restylane® Eyelight™ Trainer by Galderma
As a testament to his vast experience and expertise in the field of aesthetic medicine, Dr. Ran Rubinstein has been personally selected by Galderma to become a certified trainer for the Restylane® Eyelight™ procedure. This role highlights his extensive skills and competence in providing aesthetic treatments, especially the newly introduced under-eye shadow correction.

As a trainer, Dr. Rubinstein is responsible for teaching and guiding other professionals on how to perform this cutting-edge procedure, sharing his wealth of knowledge and expertise to ensure that the highest standards of patient care are met across the board. This position is not just an endorsement of Dr. Rubinstein's skills but a reflection of his dedication to the advancement of the industry as a whole.

About Dr. Ran Rubinstein
With a passion for helping his patients achieve their aesthetic goals, Dr. Ran Rubinstein is a board-certified facial plastic surgeon who has dedicated over 20 years to the field of cosmetic and reconstructive surgery. He leads the Laser & Cosmetic Surgery Specialists team with a commitment to excellence, offering his patients access to the most advanced and effective treatments available.

Renowned for his expertise in facial procedures, Dr. Rubinstein often mentors other practitioners in the industry, sharing his knowledge and innovative techniques. His selection as a certified national trainer for Restylane®️️️ Eyelight™ reaffirms his esteemed reputation and ongoing commitment to leading-edge patient care.

Dr. Rubinstein's dedication extends beyond his practice; he was a Clinical Professor at the New York-Presbyterian Hospital for 15 years and continues to be involved in physician education. His continuous engagement in the medical community underscores his devotion to ensuring patients receive the highest level of care and have access to the latest advancements in the field.

The opportunity to consult with Dr. Rubinstein about the Restylane® Eyelight™ treatment offers patients the unique advantage of discussing their aesthetic goals with a recognized expert in the field and a trainer for the procedure. His dedication to patient satisfaction and consistent delivery of outstanding results make Dr. Rubinstein an ideal choice for those considering Restylane® Eyelight™.

If under-eye shadows are causing you concern, consider booking a consultation with Dr. Rubinstein to discuss the benefits of Restylane® Eyelight™. For further information or to schedule an appointment, please visit the Laser & Cosmetic Surgery Specialists website or contact the practice directly at 845-863-1772.

Media Contact

Ran Y. Rubinstein, MD, Laser & Cosmetic Surgery Specialists, (845) 863-1772, info@yourfacemd.com

SOURCE Laser & Cosmetic Surgery Specialists

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.